Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 341.44M | 360.13M | 373.80M | 382.46M | 203.47M |
| Total Receivables | 2.00M | 1.90M | 1.90M | 1.50M | 700.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.02M | 3.58M | 2.88M | 6.82M | 7.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 347.46M | 365.61M | 378.57M | 390.78M | 211.67M |
|
|
|||||
| Total Current Assets | 347.46M | 365.61M | 378.57M | 390.78M | 211.67M |
| Net Property, Plant & Equipment | 7.72M | 7.98M | 8.19M | 8.01M | 8.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.38M | 7.01M | 5.69M | 5.96M | 6.03M |
| Total Assets | 363.56M | 380.59M | 392.46M | 404.74M | 225.86M |
|
|
|||||
| Total Accounts Payable | 590.00K | 1.17M | 1.58M | 2.88M | 4.66M |
| Total Accrued Expenses | 13.59M | 10.81M | 8.42M | 5.47M | 10.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 412.00K | 398.00K | 383.00K | 370.00K | 280.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.59M | 12.37M | 10.38M | 8.72M | 15.33M |
|
|
|||||
| Total Current Liabilities | 14.59M | 12.37M | 10.38M | 8.72M | 15.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.81M | 5.92M | 6.02M | 6.12M | 6.22M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.00K | 11.00K | 20.00K | 29.00K | 46.00K |
| Total Liabilities | 20.41M | 18.30M | 16.42M | 14.86M | 21.60M |
|
|
|||||
| Common Stock & APIC | 593.69M | 586.28M | 577.95M | 572.91M | 368.71M |
| Retained Earnings | -251.31M | -225.74M | -201.72M | -183.02M | -164.83M |
| Treasury Stock & Other | 770.00K | 1.75M | -184.00K | -6.00K | 381.00K |
| Total Common Equity | 343.15M | 362.29M | 376.04M | 389.88M | 204.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 343.15M | 362.29M | 376.04M | 389.88M | 204.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 343.15M | 362.29M | 376.04M | 389.88M | 204.26M |
|
|
|||||